Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
Celest Therapeutics’ Collaboration with Senti Biosciences
BioMap’s Collaboration with Sanofi
Wilson Sonsini Goodrich & Rosati advised BioMap on the transaction. BioMap announced a collaboration with Sanofi, to co-develop advanced AI modules for biotherapeutic drug discovery leveraging BioMap’s...
Boyu Capital’s Acquisition of Quasar Medical
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
Insilico Medicine’s Research Collaboration with Sanofi
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction. Insilico Medicine, a clinical-stage artificial intelligence-driven drug discovery company, announced a multi-year, multi-target strategic research...
LaNova Medicines’ License Agreement with Turning Point Therapeutics
Wilson Sonsini Goodrich & Rosati advised LaNova on the deal. Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel targeted therapies for...
Kensington Capital Acquisition Corp. IV’s Merger With Amprius Technologies
Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction while Wilson Sonsini represented Amprius Technologies. Kensington Capital Acquisition Corp. IV executed its business...
EQRx’s Collaboration with Insilico Medicine
Ropes & Gray advised EQRx in the deal while Wilson Sonsini Goodrich & Rosati represented InSilico. EQRx annlounced a strategic collaboration with Insilico Medicine to jointly...
Insilico Medicine’s Drug Discovery Collaboration with Fosun Pharma
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the deal. Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading innovation-driven international healthcare group in China, and...
Briggs & Stratton’s Acquisition of SimpliPhi Power
Wilson Sonsini Goodrich & Rosati advised SimpliPhi Power on the deal. Briggs & Stratton, a recognized global leader in providing power to get work done, has...
Shell’s Acquisition of Inspire Energy Capital
Wilson Sonsini Goodrich & Rosati advised Inspire Energy Capital on the deal. Shell New Energies US LLC, a subsidiary of Royal Dutch Shell plc, announced that...